BCDA - Biocardia Inc
Biocardia Inc Logo

BCDA - Biocardia Inc

https://www.biocardia.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.

52W High
$3.26
52W Low
$1.63
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.84
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-3.16
EV/Revenue (<3 favorable)
3111.70
P/S (TTM) (<3 favorable)
3089.53
P/B (<3 favorable)
10.67
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
18.98%
Institutions (25–75% balanced)
5.25%
Shares Outstanding
5,801,200
Float
4,328,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
-5,244,000
EPS (TTM)
-1.68
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-7.38%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
0.0596
Previous
0.0578
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025